Global Surgical Sphincteroplasty Market Report Size, Trends & Growth Opportunity, By Material, By Technology, By End Use Industry, By Region and forecast till 2027
Report ID : QR1001333 | Industries : Healthcare | Published On :January 2022 | Page Count : 240Global Surgical Sphincteroplasty Market
Sphincteroplasty is a low-cost surgery as compared to any other treatments anal incontinence. Aspects like low maintenance surgical tools and a 98.0% success ratio of sphincteroplasty have improved its adoption among surgeons.
Market Drivers
The rising prevalence of Anal Incontinence (AI), cost-effectiveness of sphincteroplasty, and increasing incidence of obstetric injury post-childbirth are the vital factors driving the market. Sphincteroplasty (SP) is highly accepted among women and geriatric patients because of its high success rates, cost efficiency, and reduced requirement for re-surgery. Several researches are undertaken in the developed nation to establish an improved non-invasive method to cure AI, which is also projected to drive the market for surgical sphincteroplasty.
Know more about this report: request for sample pages
Market Restraints
The fear of COVID 19 virus spread among patients has directed to the reduction in elective surgeries and reduced admission rates at hospitals, eventually affecting the market in 2020. Decreased surgical supplies because of the halt in logistics, and shortage of hospital care staff have led to the dip in the surgical sphincteroplasty market.
Regional Analysis
North America conquered the market for surgical sphincteroplasty and reported for the largest revenue share of 34.9% in 2020. Because of the improved healthcare infrastructure, and existence of leading market players in this region. Moreover, a growth in clinical research to establish concrete treatment options for AI is also likely to boost the market growth in the region.
Asia Pacific region also observed the highest CAGR of 7.1% throughout the forecast period. Factors like the growth in the aging population, increased adoption of cost-effective surgeries like sphincteroplasty, and improved government expenditure on the healthcare sector is likely to drive the market in the region.
Market Key Players
Some of the key players operating in Global Surgical Sphincteroplasty Market are Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., Johnson & Johnson
Industry development
In October 2021, Laborie Medical Technologies acquired Pevalon’s non-surgical segment Eclipse. The segment is responsible for marketing its largest grossing product, vaginal inserts, to treat incontinence among women.
Global Surgical Sphincteroplasty Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data End-users
3 Executive Summary
4 Surgical Sphincteroplasty Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Surgical Sphincteroplasty Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Surgical Sphincteroplasty Market Share Analysis, By Type
5.3 Surgical Sphincteroplasty Market Size and Forecast, By Type
5.3.1 Surgical
5.3.1.1 Direct apposition sphincteroplasty
5.3.1.2 Overlapping sphincteroplasty
5.3.2 non-Surgical
5.3.2.1 Sacral nerve stimulation
5.3.2.2 Vaginal balloon inserts
5.3.2.3 Others
6 Surgical Sphincteroplasty Market, By Region
6.1 Surgical Sphincteroplasty Market Share Analysis, By Region
6.2 Surgical Sphincteroplasty Market Share Analysis, By Region
6.3 Surgical Sphincteroplasty Market Size and Forecast, By Region
7 North America Surgical Sphincteroplasty Market Analysis and Forecast (2021-2027)
7.1 Introduction
7.2 North America Surgical Sphincteroplasty Market Share Analysis, By Type
7.3 North America Surgical Sphincteroplasty Market Size and Forecast, By Country
7.3.1 U.S.
7.3.2 Canada
7.3.3 Mexico
8 Europe Surgical Sphincteroplasty Market Analysis and Forecast (2021-2027)
8.1 Introduction
8.2 Europe Surgical Sphincteroplasty Market Share Analysis, By Type
8.3 Europe Surgical Sphincteroplasty Market Size and Forecast, By Country
8.3.1 Germany
8.3.2 France
8.3.3 UK
8.3.3 Rest of Europe
9 Asia Pacific Surgical Sphincteroplasty Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 Asia Pacific Surgical Sphincteroplasty Market Share Analysis, By Type
9.3 Asia Pacific Surgical Sphincteroplasty Market Size and Forecast, By Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.3. Rest of Asia Pacific
10 Latin America Surgical Sphincteroplasty Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Latin America Surgical Sphincteroplasty Market Share Analysis, By Type
10.3 Latin America Surgical Sphincteroplasty Market Size and Forecast, Country
10.3.1. Brazil
10.3.2. Rest of Latin America
11 Middle East Surgical Sphincteroplasty Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Middle East Surgical Sphincteroplasty Market Share Analysis, By Type
11.3 Middle East Surgical Sphincteroplasty Market Size and Forecast, By Country
11.3.1. Saudi Arabia
11.3.2. UAE
11.3.3. Egypt
11.3.3. Kuwait
11.3.5. South Africa
12 Competitive Analysis
12.1 Competition Dashboard
12.2 Market share Analysis of Top Vendors
12.3 Key Development Strategies
13 Company Profiles
13.1 Medtronic
13.1.1 Overview
13.1.2 Offerings
13.1.3 Key Financials
13.1.3 Business Segment & Geographic Overview
13.1.5 Key Market Developments
13.1.7 Key Strategies
13.2 Hill-Rom Services, Inc.
13.2.1 Overview
13.2.2 Offerings
13.2.3 Key Financials
13.2.3 Business Segment & Geographic Overview
13.2.5 Key Market Developments
13.2.7 Key Strategies
13.3 McKesson
13.3.1 Overview
13.3.2 Offerings
13.3.3 Key Financials
13.3.3 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.7 Key Strategies
13.3 B. Braun
13.3.1 Overview
13.3.2 Offerings
13.3.3 Key Financials
13.3.3 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.7 Key Strategies
13.5 Becton, Dickinson and Company
13.5.1 Overview
13.5.2 Offerings
13.5.3 Key Financials
13.5.3 Business Segment & Geographic Overview
13.5.5 Key Market Developments
13.5.7 Key Strategies
13.6 Novo Surgical, Inc.
13.6.1 Overview
13.6.2 Offerings
13.6.3 Key Financials
13.6.3 Business Segment & Geographic Overview
13.6.5 Key Market Developments
13.6.6 Key Strategies
13.7 Surgical Holdings
13.7.1 Overview
13.7.2 Offerings
13.7.3 Key Financials
13.7.3 Business Segment & Geographic Overview
13.7.5 Key Market Developments
13.7.6 Key Strategies
13.8 Pelvalon
13.8.1 Overview
13.8.2 Offerings
13.8.3 Key Financials
13.8.3 Business Segment & Geographic Overview
13.8.5 Key Market Developments
13.8.6 Key Strategies
13.9 Salix Pharmaceutical Inc.
13.9.1 Overview
13.9.2 Offerings
13.9.3 Key Financials
13.9.3 Business Segment & Geographic Overview
13.9.5 Key Market Developments
13.9.6 Key Strategies
13.10 Johnson & Johnson
13.10.1 Overview
13.10.2 Offerings
13.10.3 Key Financials
13.10.3 Business Segment & Geographic Overview
13.10.5 Key Market Developments
13.10.6 Key Strategies